Harvey Schneier

1.4k total citations · 1 hit paper
33 papers, 1.0k citations indexed

About

Harvey Schneier is a scholar working on Gastroenterology, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Harvey Schneier has authored 33 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Gastroenterology, 17 papers in Surgery and 8 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Harvey Schneier's work include Gastrointestinal motility and disorders (26 papers), Congenital gastrointestinal and neural anomalies (9 papers) and Intestinal Malrotation and Obstruction Disorders (9 papers). Harvey Schneier is often cited by papers focused on Gastrointestinal motility and disorders (26 papers), Congenital gastrointestinal and neural anomalies (9 papers) and Intestinal Malrotation and Obstruction Disorders (9 papers). Harvey Schneier collaborates with scholars based in United States, Ireland and United Kingdom. Harvey Schneier's co-authors include Jeffrey M. Johnston, Steven J. Shiff, Anthony Lembo, Bernard J. Lavins, James E. MacDougall, Mark G. Currie, Caroline B. Kurtz, Xinwei D. Jia, James Shao and Donald A. Fitch and has published in prestigious journals such as New England Journal of Medicine, Gastroenterology and Gut.

In The Last Decade

Harvey Schneier

32 papers receiving 948 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Linaclotide for Irritable Bowel Syndrome With Constipation: A 26-Week, Randomized, Double-blind, Placebo-Controlled Trial to Evaluate Efficacy and Safety

2012 340 citations William D. Chey, Anthony Lembo et al. The American Journal of Gastroenterology profile →

Peers

Countries citing papers authored by Harvey Schneier

Since Specialization

Citations

This map shows the geographic impact of Harvey Schneier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harvey Schneier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harvey Schneier more than expected).

Fields of papers citing papers by Harvey Schneier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harvey Schneier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harvey Schneier. The network helps show where Harvey Schneier may publish in the future.

Co-authorship network of co-authors of Harvey Schneier

This figure shows the co-authorship network connecting the top 25 collaborators of Harvey Schneier. A scholar is included among the top collaborators of Harvey Schneier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harvey Schneier. Harvey Schneier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Two Years on Linaclotide: Tolerability and Treatment Satisfaction in IBS-C Patients With and Without Diarrhea: Presidential Poster 2014 ·The American Journal of Gastroenterology ·William D. Chey, Steven J. Shiff, Harvey Schneier, (unknown), Bernard J. Lavins, (unknown), Caroline B. Kurtz, Mark G. Currie, Jeffrey Johnston	3
2	OC-082 26-Week efficacy and safety of once-daily oral linaclotide in patients with irritable bowel syndrome with constipation (IBS-C): a European perspective 2012 ·Gut ·Anthony Lembo, J Fortea, (unknown), M. Falqués, Jing Shao, Bernard J. Lavins, Harvey Schneier, JM Johnston	1
3	A 12-Week, Randomized, Controlled Trial With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Linaclotide in Irritable Bowel Syndrome With Constipation 2012 ·The American Journal of Gastroenterology ·Satish S.C. Rao, Anthony Lembo, Steven J. Shiff, Bernard J. Lavins, Mark G. Currie, Xinwei D. Jia, Kelvin Shi, James E. MacDougall, James Shao, Paul Eng, Susan M. Fox, Harvey Schneier, Caroline B. Kurtz, Jeffrey M. Johnston	293
4	Linaclotide for Irritable Bowel Syndrome With Constipation: A 26-Week, Randomized, Double-blind, Placebo-Controlled Trial to Evaluate Efficacy and Safety breakdown → 2012 ·The American Journal of Gastroenterology ·William D. Chey, Anthony Lembo, Bernard J. Lavins, Steven J. Shiff, Caroline B. Kurtz, Mark G. Currie, James E. MacDougall, Xinwei D. Jia, James Shao, Donald A. Fitch, Mollie Baird, Harvey Schneier, Jeffrey M. Johnston	340
5	Sa1098 Mediation Analysis Supports a Direct Effect of Linaclotide on Relief of Abdominal Pain Independent of Constipation Improvement 2012 ·Gastroenterology ·James E. MacDougall, David P. MacKinnon, Bernard J. Lavins, Anthony Lembo, Steven J. Shiff, Harvey Schneier, (unknown), Mark G. Currie, Jeffrey M. Johnston	4
6	Effects of Linaclotide on Abdominal and Bowel Symptoms Over the First Seven Days of Treatment in Patients with Irritable Bowel Syndrome with Constipation 2012 ·The American Journal of Gastroenterology ·Lin Chang, Anthony Lembo, Steven J. Shiff, James Shao, Bernard J. Lavins, Kelvin Shi, Harvey Schneier, Mark G. Currie, Jeffrey Johnston	1
7	Tu1423 Effects of Linaclotide on Straining Associated With Bowel Movements in Patients With Irritable Bowel Syndrome With Constipation (IBS-C): A Post Hoc Analysis of Pooled Data From Two Phase 3 Trials 2012 ·Gastroenterology ·Anthony Lembo, Satish S.C. Rao, Steven J. Shiff, Bernard J. Lavins, James E. MacDougall, Kelvin Shi, Harvey Schneier, Mark G. Currie, Jeffrey M. Johnston	1
8	Tu1065 Comparison of Responder Rates and Degree of Agreement for Symptom-Specific and Global-Relief Endpoints in Two Phase 3 Trials of Linaclotide in IBS-C 2012 ·Gastroenterology ·(unknown), (unknown), Mark G. Currie, (unknown), Kelvin Shi, Harvey Schneier, Jeffrey M. Johnston	1
9	Tu1401 Factors Contributing to Treatment Satisfaction in Patients With Irritable Bowel Syndrome With Constipation (IBS-C) Treated With Linaclotide vs Placebo 2012 ·Gastroenterology ·Anthony Lembo, Robyn T. Carson, Steven J. Shiff, Bernard J. Lavins, James E. MacDougall, Kelvin Shi, Harvey Schneier, Mark G. Currie, Jeffrey M. Johnston	10
10	Tu1380 Assessing the Percent of Days Linaclotide Improved Abdominal Symptoms and Stool Frequency in Patients With IBS-C: A Pooled Analysis of Two Phase 3 Trials 2012 ·Gastroenterology ·Satish S. Rao, Lin Chang, (unknown), Bernard J. Lavins, Steven J. Shiff, (unknown), Harvey Schneier, Mark G. Currie, Jeffrey M. Johnston	1
11	Two Randomized Trials of Linaclotide for Chronic Constipation 2011 ·New England Journal of Medicine ·Anthony Lembo, Harvey Schneier, Steven J. Shiff, Caroline B. Kurtz, James E. MacDougall, Xinwei D. Jia, James Shao, Bernard J. Lavins, Mark G. Currie, Donald A. Fitch, Brenda I. Jeglinski, Paul Eng, Susan M. Fox, Jeffrey M. Johnston	270
12	Clarification of trial end points presented in a recent review of linaclotide 2011 ·Expert Review of Gastroenterology & Hepatology ·Jeffrey M. Johnston, Harvey Schneier	3
13	Efficacy and Safety of Once Daily Linaclotide in Patients With Irritable Bowel Syndrome With Constipation: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial Followed by a 4-Week Randomized Withdrawal Period 2011 ·Gastroenterology ·Satish S.C. Rao, Anthony Lembo, Steven J. Shiff, Kelvin Shi, Jeffrey M. Johnston, Harvey Schneier	10
14	Efficacy and Safety of Once-daily Linaclotide Administered Orally for 12 Weeks to Patients with IBS-C: Pooled Results from Two Randomized, Double-blind, Placebo-Controlled Phase 3 Trials: 2011 ACG Presidential Poster 2011 ·The American Journal of Gastroenterology ·William D. Chey, Satish S.C. Rao, Anthony Lembo, (unknown), Kelvin Shi, Bernard J. Lavins, Steven J. Shiff, Harvey Schneier, Jeffrey Johnston	1
15	Efficacy and Safety of Once-daily Linaclotide Administered Orally for 12-weeks in Patients with Chronic Constipation and at Least Moderate Bloating at Baseline: Pooled Results from 2 Randomized, Double-blind, Placebo-controlled Phase 3 Trials 2011 ·The American Journal of Gastroenterology ·Anthony Lembo, Harvey Schneier, Bernard J. Lavins, Steven J. Shiff, (unknown), (unknown), Jeffrey Johnston	2
16	286 Efficacy and Safety of Once Daily Linaclotide Administered Orally for 12-Weeks in Patients With Chronic Constipation: Results From 2 Randomized, Double-Blind, Placebo-Controlled Phase 3 Trials 2010 ·Gastroenterology ·Anthony Lembo, Harvey Schneier, Bernard J. Lavins, Steven J. Shiff, James E. MacDougall, Xinwei D. Jia, Caroline B. Kurtz, Mark G. Currie, Jeffrey M. Johnston	16
17	418 Effect of Linaclotide On Quality of Life in Adults with Chronic Constipation: Results from a Phase 2B Study 2009 ·Gastroenterology ·Bernard J. Lavins, Jeffrey M. Johnston, James E. MacDougall, Anthony Lembo, Harvey Schneier, Steven J. Shiff, Robyn T. Carson, Caroline B. Kurtz, Mark G. Currie	1
18	T1273 Time to Onset of Linaclotide Effect On the Bowel Habits in Patients with Chronic Constipation: Results from a Phase 2B Study 2009 ·Gastroenterology ·Jeffrey M. Johnston, Bernard J. Lavins, James E. MacDougall, Anthony Lembo, Harvey Schneier, Steven J. Shiff, Caroline B. Kurtz, Mark G. Currie	1
19	236 Global Endpoints in IBS Clinical Trials: Results from a Phase 2B Study of Linaclotide 2009 ·Gastroenterology ·Jeffrey M. Johnston, James E. MacDougall, Bernard J. Lavins, Anthony Lembo, Harvey Schneier, Steven J. Shiff, Caroline B. Kurtz, Mark G. Currie	4
20	157 Effect of Linaclotide On IBS-C Symptoms in the First Week of Treatment: Results from a Phase 2B Study 2009 ·Gastroenterology ·Anthony Lembo, Jeffrey M. Johnston, Bernard J. Lavins, James E. MacDougall, Harvey Schneier, Steven J. Shiff, Caroline B. Kurtz, Mark G. Currie	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact